Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Melanie, Peters"'
Autor:
Niklas Frahm, David Ellenberger, Alexander Stahmann, Firas Fneish, Daniel Lüftenegger, Hans C. Salmen, Ksenija Schirduan, Tom P. A. Schaak, Peter Flachenecker, Christoph Kleinschnitz, Friedemann Paul, Dagmar Krefting, Uwe K. Zettl, Melanie Peters, Clemens Warnke
Publikováno v:
Therapeutic Advances in Neurological Disorders, Vol 17 (2024)
Background: The spectrum of disease-modifying therapies (DMTs) for people with multiple sclerosis (PwMS) has expanded over years, but data on treatment strategies is largely lacking. DMT switches are common clinical practice. Objective: To compare sw
Externí odkaz:
https://doaj.org/article/c8eeaeea69924efc9284aba8da3cbdca
Autor:
Firas Fneish, Niklas Frahm, Melanie Peters, David Ellenberger, Judith Haas, Micha Löbermann, Dieter Pöhlau, Anna-Lena Röper, Sarah Schilling, Alexander Stahmann, Herbert Temmes, Friedemann Paul, Uwe K. Zettl
Publikováno v:
Vaccines, Vol 11, Iss 12, p 1859 (2023)
Several studies reported post-SARS-CoV-2-vaccination (PV) symptoms. Even people with multiple sclerosis (PwMS) have concerns about disease activity following the SARS-CoV-2 vaccination. We aimed to determine the proportion of PwMS with PV relapses, t
Externí odkaz:
https://doaj.org/article/fd7179958544494b9322499460d272e4
Autor:
Niklas Frahm, Firas Fneish, David Ellenberger, Judith Haas, Micha Loebermann, Tina Parciak, Melanie Peters, Dieter Pöhlau, Jeff Rodgers, Anna-Lena Röper, Sarah Schilling, Alexander Stahmann, Herbert Temmes, Uwe K. Zettl, Rodden M. Middleton
Publikováno v:
The Lancet Regional Health. Europe, Vol 22, Iss , Pp 100502- (2022)
Summary: Background: Vaccines offer people with multiple sclerosis (PwMS) an effective protection against severe COVID-19 disease courses. However, representative real-world data on the tolerability of SARS-CoV-2 vaccines in PwMS are limited. We aime
Externí odkaz:
https://doaj.org/article/9a6b3486974f4051a56463f363e21125
Autor:
Niklas Frahm, Melanie Peters, Jörg Bätzing, David Ellenberger, Manas K. Akmatov, Judith Haas, Paulus S. Rommer, Alexander Stahmann, Uwe K. Zettl, Jakob Holstiege
Publikováno v:
Therapeutic Advances in Neurological Disorders, Vol 14 (2021)
Background: The manifestation of multiple sclerosis (MS) in childhood and adolescence occurs in 3%−5% of all MS cases. However, the immunomodulatory and symptomatic treatment options in this population group are still limited. Objective: We aimed t
Externí odkaz:
https://doaj.org/article/5aa4ca49ffe54e85a974a9dbbd0a8893
Autor:
Niklas Frahm, Firas Fneish, David Ellenberger, Melanie Peters, Herbert Temmes, Alexander Stahmann
Publikováno v:
NeuroTransmitter. 33:40-44
Autor:
Niklas Frahm, Firas Fneish, David Ellenberger, Judith Haas, Micha Löbermann, Melanie Peters, Dieter Pöhlau, Anna-Lena Röper, Sarah Schilling, Alexander Stahmann, Herbert Temmes, Friedemann Paul, Uwe Klaus Zettl
Publikováno v:
Journal of Clinical Medicine; Volume 12; Issue 11; Pages: 3640
Despite protection from severe COVID-19 courses through vaccinations, some people with multiple sclerosis (PwMS) are vaccination-hesitant due to fear of post-vaccination side effects/increased disease activity. The aim was to reveal the frequency and
Publikováno v:
B en M: tijdschrift voor beleid, politiek en maatschappij, 183-190
STARTPAGE=183;ENDPAGE=190;ISSN=1389-0069;TITLE=B en M: tijdschrift voor beleid, politiek en maatschappij
STARTPAGE=183;ENDPAGE=190;ISSN=1389-0069;TITLE=B en M: tijdschrift voor beleid, politiek en maatschappij
Technological advancements in the field of data analytics, algorithms and AI have dramatically increased opportunities for workplace monitoring. In this article, we discuss some of these digital technologies, and examine their impact on employment re
Autor:
Jörg Bätzing, Judith Haas, Niklas Frahm, Manas K. Akmatov, Jakob Holstiege, Paulus S. Rommer, Melanie Peters, David Ellenberger, Uwe K. Zettl, Alexander Stahmann
Publikováno v:
Therapeutic Advances in Neurological Disorders, Vol 14 (2021)
Therapeutic Advances in Neurological Disorders
Therapeutic Advances in Neurological Disorders
Background: The manifestation of multiple sclerosis (MS) in childhood and adolescence occurs in 3%−5% of all MS cases. However, the immunomodulatory and symptomatic treatment options in this population group are still limited. Objective: We aimed t
Autor:
Manas K. Akmatov, Judith Haas, Alexander Stahmann, Paulus S. Rommer, Niklas Frahm, Uwe K. Zettl, Melanie Peters, David Ellenberger, Jörg Bätzing, Jakob Holstiege
Publikováno v:
European journal of neurologyREFERENCES. 28(9)
BACKGROUND AND PURPOSE Prevalence data are needed to reveal trends regarding the pediatric multiple sclerosis (MS) situation worldwide. The aim was to identify changes in MS diagnosis prevalence in pediatric patients over a 10-year period in Germany.
Autor:
Yanling Liao, Morgan Anderson-Crannage, Edo Schaefer, Bruno Hochberg, Jian Pan, Melanie Peters, Mitch S. Cairo
Publikováno v:
Transplantation and Cellular Therapy. 28:S215